NCT06655220View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

December 8, 2024

Study Completion Date

January 13, 2025

Conditions
Healthy
Interventions
DRUG

Metformin hydrochloride

Metformin hydrochloride

DRUG

BI 1815368

BI 1815368

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06655220 - A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body | Biotech Hunter | Biotech Hunter